- Home
- NCMI vs QSI Comparison
NCMI vs QSI Comparison
Compare NCMI & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCMI | QSI |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.0M | 165.6M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NCMI | QSI |
|---|---|---|
| Price | $1.59 | $1.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $4.44 | $2.28 |
| AVG Volume (30 Days) | 621.4K | ★ 9.1M |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | ★ 5.56% | N/A |
| EPS Growth | ★ 52.17 | 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | $9.27 | N/A |
| Revenue Next Year | $2.48 | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.43 | $0.69 |
| 52 Week High | $4.34 | $1.81 |
Technical Indicators
Market Signals| Indicator | NCMI | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 28.85 | 51.28 |
| Support Level | N/A | $0.81 |
| Resistance Level | $2.30 | $1.73 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 26.47 | 35.06 |
Price Performance
Historical ComparisonAbout NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.